Last Price$311.50.9%
Market Cap$87.2B
LTM FCF to Net Income
246.6%
5Y avg
153.5%
Medical - Healthcare Plans industry
median
107.1%
Stock quality & Intrinsic value
6/10
2.0% undervalued
Cigna Corporation FCF to Net Income
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF to Net Income | 88.6% | 51.5% | 43.7% | 96.4% | 485.8% | 33.6% | 107.0% | 80.5% | 119.6% | 13.0% | 72.6% | 106.3% | 193.4% | 162.0% | 122.5% | 164.7% | 109.0% | 111.5% | 109.1% | 198.3% |
Overvalued or undervalued?
Check the intrinsic value for CI
and see if it's the right time to invest.
Cigna Corporation (CI) FCF to Net Income comparison analysis
General
LTM FCF to Net Income
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Cigna CorporationCI
246.6%
8.4%
(18.9%)
2.6%
Median Peer Set
107.1%
7.4%
(2.4%)
1.1%
Oscar Health, Inc.OSCR
3,638.1%
56.5%
N/A
0.3%
Bright Health Group, Inc.BHG
224.0%
(51.9%)
86.2%
(103.4%)
Humana Inc.HUM
196.5%
10.7%
(50.1%)
1.0%
UnitedHealth Group IncorporatedUNH
143.7%
8.9%
(35.7%)
3.6%
CVS Health CorporationCVS
137.9%
4.2%
(43.6%)
1.2%
Elevance Health Inc.ELV
76.2%
3.2%
(0.0%)
3.4%
Molina Healthcare, Inc.MOH
46.1%
19.3%
9.2%
2.9%
Alignment Healthcare, Inc.ALHC
5.2%
27.2%
(4.8%)
(8.1%)
Centene CorporationCNC
(14.9%)
5.9%
27.4%
2.0%
Clover Health Investments, Corp.CLOV
(613.4%)
(41.5%)
(31.3%)
(10.5%)
CI key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 18,176.0 0.0% | 16,684.0 (8.2%) | 16,547.0 (0.8%) | 17,623.0 6.5% | 19,101.0 8.4% | 18,414.0 (3.6%) | 21,253.0 15.4% | 21,998.0 3.5% | 29,119.0 32.4% | 32,380.0 11.2% | 34,914.0 7.8% | 37,876.0 8.5% | 40,007.0 5.6% | 42,043.0 5.1% | 48,569.0 15.5% | 153,743.0 216.5% | 160,550.0 4.4% | 174,267.0 8.5% | 180,031.0 3.3% | 195,187.0 8.4% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
% margin | 18,176.0 100.0% | 16,684.0 100.0% | 16,547.0 100.0% | 17,623.0 100.0% | 19,101.0 100.0% | 18,414.0 100.0% | 21,253.0 100.0% | 21,998.0 100.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Operating Expenses | (15,940.0) | 14,891.0 | 14,816.0 | 15,990.0 | 18,719.0 | 16,516.0 | 19,326.0 | 19,989.0 | 26,374.0 | 0.0 | 0.0 | 0.0 | 36,919.0 | 38,101.0 | 44,409.0 | 145,666.0 | 152,397.0 | 166,326.0 | 171,581.0 | 186,651.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 0.0 | 0.0 | 0.0 | 0.0 | 5,535.0 | 5,450.0 | 5,744.0 | 5,901.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9,750.0 | 9,830.0 | 11,141.0 | 13,315.0 | 13,660.0 | 12,791.0 | 13,110.0 | 14,370.0 |
% margin | 2,236.0 12.3% | 1,793.0 10.7% | 1,731.0 10.5% | 1,626.0 9.2% | 382.0 2.0% | 1,896.0 10.3% | 2,048.0 9.6% | 2,169.0 9.9% | 2,875.0 9.9% | 32,380.0 100.0% | 34,914.0 100.0% | 37,876.0 100.0% | 3,088.0 7.7% | 3,942.0 9.4% | 4,160.0 8.6% | 8,077.0 5.3% | 8,153.0 5.1% | 7,941.0 4.6% | 8,450.0 4.7% | 8,536.0 4.4% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 166.0 | 182.0 | 202.0 | 0.0 | 264.0 | 0.0 | 0.0 | 278.0 | 252.0 | 498.0 | 1,682.0 | 1,438.0 | 1,208.0 | 1,228.0 | 1,446.0 |
| Pre-tax Income | 2,375.0 | 1,793.0 | 1,731.0 | 1,631.0 | 378.0 | 1,898.0 | 1,870.0 | 1,968.0 | 2,477.0 | 2,176.0 | 3,304.0 | 3,327.0 | 2,979.0 | 3,606.0 | 3,581.0 | 6,570.0 | 10,868.0 | 6,790.0 | 8,397.0 | 5,513.0 |
% effective tax rate | 798.0 33.6% | 517.0 28.8% | 572.0 33.0% | 511.0 31.3% | 90.0 23.8% | 594.0 31.3% | 521.0 27.9% | 640.0 32.5% | 853.0 34.4% | 698.0 32.1% | 1,210.0 36.6% | 1,250.0 37.6% | 1,136.0 38.1% | 1,374.0 38.1% | 935.0 26.1% | 1,450.0 22.1% | 2,379.0 21.9% | 1,370.0 20.2% | 1,615.0 19.2% | 141.0 2.6% |
% margin | 1,438.0 7.9% | 1,625.0 9.7% | 1,155.0 7.0% | 1,115.0 6.3% | 292.0 1.5% | 1,302.0 7.1% | 1,345.0 6.3% | 1,327.0 6.0% | 1,623.0 5.6% | 1,476.0 4.6% | 2,102.0 6.0% | 2,094.0 5.5% | 1,867.0 4.7% | 2,237.0 5.3% | 2,637.0 5.4% | 5,104.0 3.3% | 8,458.0 5.3% | 5,370.0 3.1% | 6,704.0 3.7% | 5,164.0 2.6% |
| EPS | 3.51 | 4.25 | 3.49 | 3.94 | 1.05 | 4.75 | 4.69 | 4.65 | 5.70 | 5.28 | 7.97 | 8.17 | 7.31 | 8.92 | 10.69 | 13.58 | 23.17 | 15.89 | 21.66 | 17.57 |
| Diluted EPS | 3.48 | 4.17 | 3.43 | 3.87 | 1.05 | 4.73 | 4.65 | 4.59 | 5.61 | 5.18 | 7.83 | 8.04 | 7.19 | 8.77 | 10.54 | 13.44 | 22.96 | 15.75 | 21.41 | 17.39 |
% margin | 2,098.0 11.5% | 1,990.0 11.9% | 1,895.0 11.5% | 1,780.0 10.1% | 351.0 1.8% | 2,073.0 11.3% | 2,343.0 11.0% | 2,508.0 11.4% | 3,434.0 11.8% | 32,977.0 101.8% | 35,502.0 101.7% | 38,295.0 101.1% | 3,472.0 8.7% | 4,187.0 10.0% | 4,082.0 8.4% | 10,916.0 7.1% | 14,477.0 9.0% | 10,413.0 6.0% | 12,908.0 7.2% | 9,574.0 4.9% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Cigna Corporation's FCF to Net Income?
As of today, Microsoft Corp's last 12-month FCF to Net Income is 246.6%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual FCF to Net Income for Cigna Corporation have been 158.9% over the past three years, and 161.1% over the past five years.
2) Is Cigna Corporation's FCF to Net Income Good?
As of today, Cigna Corporation's FCF to Net Income is 246.6%, which is higher than industry median of 107.1%. It indicates that Cigna Corporation's FCF to Net Income is Good.